abstract |
Sirtuin modulators, particularly sirtuin activators, are useful for the treatment of visual impairment. In general, sirtuin modulators inhibit the progression of visual dysfunction caused by various eye disorders. The present invention also includes pharmaceutically acceptable formulations of sirtuin modulators, particularly ophthalmically acceptable formulations. The present invention discloses compositions and methods for treating eye disorders that result in visual impairment or blindness (blindness). Specifically, the present invention discloses a method for treating visual dysfunction due to retinal or optic nerve damage. |